Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Roos

Showing results (411-420 of 608) with videos related to

Pageof 61
Sort By:
Journal of the National Cancer Institute|December 18, 1991
Human IgM monoclonal antibody 16.88: pharmacokinetics and immunogenicity in colorectal cancer patientsH J Haisma, H M Pinedo, M A Kessel, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 22, 2007
Quality of life in couples living with Huntington's disease: the role of patients' and partners' illness perceptionsA A Kaptein, M Scharloo, D I Helder, et al.
Curationis|December 1, 1996
A formative model for student nurse development and evaluation--Part 1--Developing the modelA S van der Merwe, E C Roos, M Mulder, et al.
Frontiers in Surgery|October 18, 2019
MRI-Fusion Targeted vs. Systematic Prostate Biopsy-How Does the Biopsy Technique Affect Gleason Grade Concordance and Upgrading After Radical Prostatectomy?Jessica Rührup, Felix Preisser, Lena Theißen, et al.
International Urology and Nephrology|September 18, 2015
Concomitant Gleason Score ≥ 7 prostate cancer is an independent prognosticator for poor survival in nonmetastatic bladder cancer patients undergoing radical cystoprostatectomyChristian Thomas, Alexander Giesswein, Michael Hainz, et al.
Sleep|January 5, 2013
Suprachiasmatic nucleus neuropeptide expression in patients with Huntington's DiseaseDaniel J van Wamelen, N Ahmad Aziz, Jasper J Anink, et al.
Clinical Cardiology|April 19, 2020
Atrial fibrillation fingerprinting; spotting bio-electrical markers to early recognize atrial fibrillation by the use of a bottom-up approach (AFFIP): Rationale and designRoeliene Starreveld, Paul Knops, Kennedy S Ramos, et al.
Human Brain Mapping|April 24, 2018
Natural biological variation of white matter microstructure is accentuated in Huntington's diseaseSarah Gregory, Helen Crawford, Kiran Seunarine, et al.
Neurology|March 22, 2022
Reader Response: Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington DiseaseThomas D Bird, Herwig Lange, Travis Cruickshank, et al.
British Journal of Cancer|January 1, 1997
Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patientsR de Bree, J C Roos, M A Plaizier, et al.
Pageof 61

Showing results (411-420 of 608) with videos related to

Sort By:
Pageof 61
Journal of the National Cancer Institute|December 18, 1991
Human IgM monoclonal antibody 16.88: pharmacokinetics and immunogenicity in colorectal cancer patientsH J Haisma, H M Pinedo, M A Kessel, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 22, 2007
Quality of life in couples living with Huntington's disease: the role of patients' and partners' illness perceptionsA A Kaptein, M Scharloo, D I Helder, et al.
Curationis|December 1, 1996
A formative model for student nurse development and evaluation--Part 1--Developing the modelA S van der Merwe, E C Roos, M Mulder, et al.
Frontiers in Surgery|October 18, 2019
MRI-Fusion Targeted vs. Systematic Prostate Biopsy-How Does the Biopsy Technique Affect Gleason Grade Concordance and Upgrading After Radical Prostatectomy?Jessica Rührup, Felix Preisser, Lena Theißen, et al.
International Urology and Nephrology|September 18, 2015
Concomitant Gleason Score ≥ 7 prostate cancer is an independent prognosticator for poor survival in nonmetastatic bladder cancer patients undergoing radical cystoprostatectomyChristian Thomas, Alexander Giesswein, Michael Hainz, et al.
Sleep|January 5, 2013
Suprachiasmatic nucleus neuropeptide expression in patients with Huntington's DiseaseDaniel J van Wamelen, N Ahmad Aziz, Jasper J Anink, et al.
Clinical Cardiology|April 19, 2020
Atrial fibrillation fingerprinting; spotting bio-electrical markers to early recognize atrial fibrillation by the use of a bottom-up approach (AFFIP): Rationale and designRoeliene Starreveld, Paul Knops, Kennedy S Ramos, et al.
Human Brain Mapping|April 24, 2018
Natural biological variation of white matter microstructure is accentuated in Huntington's diseaseSarah Gregory, Helen Crawford, Kiran Seunarine, et al.
Neurology|March 22, 2022
Reader Response: Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington DiseaseThomas D Bird, Herwig Lange, Travis Cruickshank, et al.
British Journal of Cancer|January 1, 1997
Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patientsR de Bree, J C Roos, M A Plaizier, et al.
Pageof 61